12 Jan 2018
Prof. Jose M Mato, general director at CIC bioGUNE, discusses the use of NMR spectroscopy for metabolic profiling and screening of populations, and how the migration of advanced technology from translational research to the field of clinical diagnostics is enabling a personalized medicine approach for the future.
Founder CIC bioGUNE
José M Mato is founder and General Director of the Centers bioGUNE (Bilbao) and biomaGUNE (San Sebastián), and Research Professor of the Spanish National Research Council (CSIC), Spain. A graduate in Biochemistry at the Complutense University of Madrid, Professor Mato received a PhD degree from Leiden University and was awarded the CJ Kok prize for his thesis.